58 related articles for article (PubMed ID: 11027532)
1. TGF-beta1 inhibits BRCA1 expression through a pathway that requires pRb.
Satterwhite DJ; Matsunami N; White RL
Biochem Biophys Res Commun; 2000 Sep; 276(2):686-92. PubMed ID: 11027532
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein.
Satterwhite DJ; White RL; Matsunami N; Neufeld KL
Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 (TGF-beta 1) inhibits retinoblastoma gene expression but not pRB phosphorylation in TGF-beta 1-growth stimulated colon carcinoma cells.
Yan Z; Hsu S; Winawer S; Friedman E
Oncogene; 1992 Apr; 7(4):801-5. PubMed ID: 1565477
[TBL] [Abstract][Full Text] [Related]
4. Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD.
Ye L; Zhang HY; Wang H; Yang GH; Bu H; Zhang L; Wang SL
Chin Med J (Engl); 2005 Apr; 118(8):678-86. PubMed ID: 15899124
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 induces junB mRNA accumulation, G1-phase arrest, and pRb dephosphorylation in human leukemia HL-60 cells.
Pacherník J; Soucek K; Hampl A; Hofmanová J; Kozubík A
Folia Biol (Praha); 2001; 47(1):32-5. PubMed ID: 11232867
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt.
Ju EM; Choi KC; Hong SH; Lee CH; Kim BC; Kim SJ; Kim IH; Park SH
Biochem Biophys Res Commun; 2005 Mar; 328(4):1170-81. PubMed ID: 15708000
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
9. [Transforming growth factor-beta1 stimulates matrix metalloproteinase-9 production through ERK activation pathway and upregulation of Ets-1 protein].
Huang HC; Liu SY; Liang Y; Liu Y; Li JZ; Wang HY
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):328-31. PubMed ID: 15854510
[TBL] [Abstract][Full Text] [Related]
10. p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells.
Fan G; Ma X; Wong PY; Rodrigues CM; Steer CJ
Apoptosis; 2004 Mar; 9(2):211-21. PubMed ID: 15004518
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
12. The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells.
Park WH; Seol JG; Kim ES; Binderup L; Koeffler HP; Kim BK; Lee YY
Int J Oncol; 2002 Mar; 20(3):533-42. PubMed ID: 11836565
[TBL] [Abstract][Full Text] [Related]
13. [Effect of aldose reductase expression by transforming growth factor-beta1 on rat mesangial cell].
Lin W; Zhang N; Qin R
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(12):744-7. PubMed ID: 11798960
[TBL] [Abstract][Full Text] [Related]
14. A-type lamins are essential for TGF-beta1 induced PP2A to dephosphorylate transcription factors.
Van Berlo JH; Voncken JW; Kubben N; Broers JL; Duisters R; van Leeuwen RE; Crijns HJ; Ramaekers FC; Hutchison CJ; Pinto YM
Hum Mol Genet; 2005 Oct; 14(19):2839-49. PubMed ID: 16115815
[TBL] [Abstract][Full Text] [Related]
15. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
16. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta.
Zhao X; Ramsey KE; Stephan DA; Russell P
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4023-34. PubMed ID: 15505052
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty.
Kingston PA; Sinha S; Appleby CE; David A; Verakis T; Castro MG; Lowenstein PR; Heagerty AM
Circulation; 2003 Dec; 108(22):2819-25. PubMed ID: 14638551
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis.
Halder SK; Anumanthan G; Maddula R; Mann J; Chytil A; Gonzalez AL; Washington MK; Moses HL; Beauchamp RD; Datta PK
Cancer Res; 2006 Jun; 66(12):6156-66. PubMed ID: 16778189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
